Logo image of FRTX

FRESH TRACKS THERAPEUTICS IN (FRTX) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:FRTX - US10802T2042 - Common Stock

0.79 USD
-0.02 (-2.48%)
Last: 12/18/2023, 8:00:00 PM
0.77 USD
-0.02 (-2.53%)
After Hours: 12/18/2023, 8:00:00 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to FRTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.59. This target is 481.01% above the current price.
FRTX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about FRTX.
In the previous month the buy percentage consensus was at a similar level.
FRTX was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

FRTX Historical Analyst RatingsFRTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.794.554.594.594.73 - 475.32% 481.01% 481.01% 498.10%

Related screens

FRTX Current Analyst RatingFRTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

FRESH TRACKS THERAPEUTICS IN / FRTX FAQ

What do analysts expect the price target to be for FRESH TRACKS THERAPEUTICS IN (FRTX)?

7 analysts have analysed FRTX and the average price target is 4.59 USD. This implies a price increase of 481.01% is expected in the next year compared to the current price of 0.79.


What is the consensus rating for FRESH TRACKS THERAPEUTICS IN (FRTX) stock?

The consensus rating for FRESH TRACKS THERAPEUTICS IN (FRTX) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for FRTX stock?

The number of analysts covering FRESH TRACKS THERAPEUTICS IN (FRTX) is 7.